Prokinetics and Body Surface Gastric Mapping in Dyspeptic Patients: Baseline and Treatment Effects
A legfontosabb adatok
- Hol
- Philadelphia (Egyesült Államok)A helyszín megnézése
Helyszínek itt: Egyesült Államok
- Temple UniversityPhiladelphia, Egyesült ÁllamokContact: Henry Parkman, PhD/MDToborzás még nem indult
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakA vizsgálat adatai
- Ki végzi
- University of Auckland, New Zealand
- Azonosító
- NCT06854120
- A regiszteradat frissítve
- 2026. június 11.
- Eredeti leírás
Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with gastric emptying tests, although the correlation with symptoms is weak. Prokinetic agents (e.g., metoclopramide, erythromycin) and symptom modulators (e.g., nortriptyline, mirtazapine) are commonly used, but selecting the right medication can be difficult, as it's often based on symptoms rather than the underlying gastric issues. Body Surface Gastric Mapping (BSGM) using the Gastric Alimetry device is a novel, non-invasive tool to assess gastric myoelectrical activity and symptoms. This study aims to perform two BSGM recordings-one before and one after medical therapy-to understand how medications affect gastric function and identify baseline BSGM factors that could predict responses to treatment, potentially guiding tailored therapies based on individual gastric dysfunction.A teljes eredeti leírásKevesebb
Body Surface Gastric Mapping in Patients With Dyspeptic Symptoms: Recordings at Baseline and on Medical Therapy
Functional dyspepsia and gastroparesis are common stomach disorders with symptoms like early satiety, nausea, and abdominal pain, and are often evaluated with gastric emptying tests, although the correlation with symptoms is weak. Prokinetic agents (e.g., metoclopramide, erythromycin) and symptom modulators (e.g., nortriptyline, mirtazapine) are commonly used, but selecting the right medication can be difficult, as it's often based on symptoms rather than the underlying gastric issues. Body Surface Gastric Mapping (BSGM) using the Gastric Alimetry device is a novel, non-invasive tool to assess gastric myoelectrical activity and symptoms. This study aims to perform two BSGM recordings-one before and one after medical therapy-to understand how medications affect gastric function and identify baseline BSGM factors that could predict responses to treatment, potentially guiding tailored therapies based on individual gastric dysfunction.
Bevonási feltételek: Patients 18 years of age and older; Diagnosis of gastroparesis and/or functional dyspepsia; Being prescribed a prokinetic agent or symptom modulator for their clinical care; Able to undergo BSGM recording both before and during treatment; Able to give informed consent for undergoing a baseline BSGM recording and an additional recording while on treatment.
Kizáró feltételek: Prior surgery on esophagus, stomach (appendectomy and cholecystectomy are allowed); History of skin allergies or a history of extreme sensitivity to cosmetics or lotions; No vulnerable groups such as prisoners, individuals with known cognitive impairment, or institutionalized individuals be involved; Under 18 years of age; Pregnant women.